10 Largest Generic Drug Companies

Page 8 of 10

3. Mylan (NASDAQ: VTRS

Revenue – $11,500 million

Number Of Employees – 35,000

Market Cap – 21.447B

TTM  $- 11,514 million

Netherlands global generic giant Mylan has always been one of the strong players in the market. However, as pointed earlier, the company is now part of Pfizer and recently in November 2020, Mylan merged with Pfizer’s generic medicine division Upjohn as spin-off company Viatris was formed. 

Mylan Inc. (NASDAQ:MYL)

Page 8 of 10